期刊文献+

奥扎格雷钠与疏血通联合应用治疗急性脑梗死疗效观察 被引量:2

下载PDF
导出
摘要 目的:探讨奥扎格雷钠与疏血通治疗急性脑梗死的临床疗效。方法:应用奥扎格雷钠与疏血通联合应用治疗急性脑梗死患者64例,随机分成对照组和观察组,每组32例,观察组应用奥扎格雷钠与疏血通联合应用治疗,对照组应用疏血通注射液治疗,疗程均14天。结果:观察组32例,基本痊愈12例(37.5%),显著进步11例(34.4%),进步7例(17.5%),无变化2例(6.25%),总有效率93.75%;对照组基本痊愈7例(17.5%),显著进步6例(15.0%),进步7例(17.5%),无变化12例(37.5%),总有效率62.5%,两组比较有显著性差异(P<0.05)。结论:奥扎格雷钠与疏血通联合应用治疗急性脑梗死安全、有效。
作者 赵冰
出处 《中国社区医师(医学专业)》 2012年第11期41-41,共1页
  • 相关文献

参考文献5

  • 1Terao S,Takatsu S,Lzumi.Central facial weakness due to medial medullary infarction:the course of facial corticobulbar fibres[J].J Neurol Neurosurg Psychiatry,1997,63(3):391.
  • 2Berger C,Fionelli M,Steiner T,et al.Hemorrhagic transformation of ischemic brain tissue:asymptomatic or symptomatic.Stroke,2001,32:1330-1335.
  • 3Kunz S,Grises H,Busse O.Etiology and long-term prognosis of unilateral paramedian pontine infarction with progressive symptoms[J].Eur Neurol,2003,50(3):136-140.
  • 4董强,韩翔,王伟,薛骏,吕传真.HELP治疗急性脑梗死的初步疗效观察[J].中华物理医学与康复杂志,2004,26(6):369-371. 被引量:16
  • 5Imamura T,Kiguchi S,Kobayashi K,et al.Effect of ozagrel,a selective thromboxane A2synthetase inhibitor,on cerebralinfarction in rats.Comparative study with norphenazone,a freeradical scavenger[J].Arzneimittelforschung,2003,53(8):688-694.

二级参考文献19

  • 1Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke, 1997,28:2119-2125.
  • 2Jaeger BR. The HELP system for the treatment of atherothrombotic disorders: a review. Therap Apher Dial ,2003,7:391-396.
  • 3Suckfull M,Seidel D,Thiery J,et al. Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial. Z Kardiol,2003 ,92 :III59-III63.
  • 4Ridker PM. Cardiology patient page. C-reactive protein:a simple test to help predict risk of heart attack and stroke. Circulation,2003,108 :e81-e85.
  • 5Jaeger BR, Goehring P,Schirmer J, et al. Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability:a different pathophysiological approach. Ther Apher,2001,5:252-259.
  • 6Wurzner R, Schuff-Werner P, Franzke A, et al. Complement activation and depletion during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation (HELP). Eur J Clin Invest, 1991,21:288-294.
  • 7Schettler V, Methe H, Schuff-Werner P, et al. Acute effect of HELP treatment on radical scavenging enzyme activities,total glutathione concentrations in granulocytes,and selenium in plasma. Eur J Clin Invest,2000,30:26-32.
  • 8Bosch T. Recent advances in therapeutic apheresis. J Artif Organs,2003,6: 1-8.
  • 9Ernst E. Plasma fibrinogen-an independent cardiovascular risk factor. J Intern Med, 1990,227:365-372.
  • 10Walzl M, Schied G, Walzl B. Effects of ameliorated haemorheology on clinical symptoms in cerebrovascular disease. Atherosclerosis, 1998,139:385-389.

共引文献15

同被引文献30

引证文献2

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部